An open label, single-arm, phase II multicenter study of the safety and efficacy of CG0070 oncolytic vector regimen in patients with BCG-unresponsive non–muscle-invasive bladder cancer: Interim results

Vignesh T. Packiam, Gary D. Steinberg, Daniel A. Barocas et al.|Urologic Oncology Seminars and Original Investigations|2017

Cited by 250